Stock of the Day for November 3, 2024

Danaher Stock Report

Danaher
DHR 90-day performance NYSE:DHR Danaher
Current Price
$190.07
-5.09 (-2.61%)
(As of 09/12/2025 03:59 PM ET)
30 Day Performance
-9.85%
  
  
90 Day Performance
-2.93%
  
  
1 Year Performance
-30.69%
  
  
Market Capitalization
$136.10B
P/E Ratio
40.44
Dividend Yield
0.67%

About Danaher

Danaher Corporation is a global science and technology innovator that designs, manufactures and markets professional instrumentation and industrial technological products. The company operates through three primary segments—Life Sciences, Diagnostics, and Environmental & Applied Solutions—offering a broad range of products that support research, healthcare delivery and environmental monitoring. Its Life Sciences segment provides reagents, consumables and instruments under brands such as Beckman Coulter and Leica Microsystems, while the Diagnostics segment offers molecular diagnostics, clinical chemistry and virology solutions under businesses including Cepheid and Beckman Coulter Diagnostics. The Environmental & Applied Solutions segment delivers water quality analyzers, fluid management systems and code-printing equipment through brands like Hach, Videojet and Pall Corporation.

Headquartered in Washington, D.C., Danaher was founded in 1969 and adopted its current name in the mid-1980s. Since its inception, the company has pursued disciplined growth through a combination of organic investment and strategic acquisitions, leveraging the Danaher Business System—a continuous improvement framework focused on lean manufacturing, customer-centric innovation and talent development. Over the years, Danaher has expanded its footprint to serve researchers, clinicians and industrial customers in more than 60 countries worldwide.

Danaher’s products support critical applications across pharmaceutical development, academic research, clinical laboratories, food and beverage safety, and environmental testing. In life sciences, the company’s instruments and consumables enable genomic sequencing, flow cytometry and microscopy. In diagnostics, its platforms deliver rapid molecular testing and advanced immunoassays. In environmental and applied markets, Danaher’s solutions ensure safe drinking water, efficient industrial processes and accurate product identification.

Under the leadership of President and Chief Executive Officer Rainer Blair, who assumed the role in 2016, Danaher continues to emphasize innovation and operational excellence. The company employs approximately 69,000 people across North America, Europe, Asia-Pacific and Latin America, maintaining research facilities, manufacturing sites and customer support centers around the globe. Danaher’s diversified portfolio and commitment to continuous improvement position it as a leading partner for organizations seeking to advance scientific discovery and improve global health and sustainability.

DHR Company Calendar

JUL. 22, 2025
Last Earnings
JUL. 25, 2025
Dividend Payable
SEP. 15, 2025
Today
SEP. 26, 2025
Ex-Dividend for 10/31 Dividend
OCT. 28, 2025
Next Earnings (Estimated)
OCT. 31, 2025
Dividend Payable
DEC. 31, 2025
Fiscal Year End
JAN. 1, 2100
Ex-Dividend for 7/25 Dividend

Recent Danaher News

Neville Rodie & Shaw Inc. Sells 30,168 Shares of Danaher Corporation $DHR
Park National Corp OH Raises Stake in Danaher Corporation $DHR
First National Bank Sioux Falls Makes New Investment in Danaher Corporation $DHR
Danaher Corporation $DHR Stake Boosted by Acadian Asset Management LLC
2,054 Shares in Danaher Corporation $DHR Acquired by Caxton Associates LLP
Swedbank AB Trims Stock Holdings in Danaher Corporation $DHR
Voya Investment Management LLC Grows Stake in Danaher Corporation $DHR
Howe & Rusling Inc. Buys 15,897 Shares of Danaher Corporation $DHR
This report was written by MarketBeat.com on September 15, 2025. This report first appeared on MarketBeat.com.